Keros Therapeutics, Inc. · NASDAQ:KROS
Seehra Jasbir exercised options for 55,000 Keros Therapeutics, Inc. shares (Form 4)
Traded Apr 2, 2026 · Filed Apr 6, 2026
On Apr 2, 2026, Seehra Jasbir (Director, CHIEF EXECUTIVE OFFICER) exercised options for 55,000 Keros Therapeutics, Inc. shares at US$0.30 for US$16,500, leaving 440,708 shares. Filed Apr 6, 2026 (Form 4).
- Options exercised
- 55,000 shares
- Price
- US$0.30
- Value
- US$16,500
- Holding after
- 440,708 shares
- Trading plan
- No
- Role
- Director, CHIEF EXECUTIVE OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 2, 2026 | Common Stock | Option exercise | 55,000 | US$0.30 | 440,708 | Direct |